Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1988-04-13
1989-11-28
Maples, John S
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
548542, 530389, 530402, A61K 4902, A61K 39395, C07D20746
Patent
active
048836508
ABSTRACT:
The novel N-hydroxysuccinimide ester of iodohippuric acid (IH-OSU), capable of forming a stable conjugate with a protein. The iodohippuric acid is preferably orthoiodohippuric acid (OIH) and radiolabeled. A protein compound useful as a radiolable comprises a stable conjugate of a protein and the N-hydroxysuccinimide ester of radiolabeled iodohippuric acid.
REFERENCES:
patent: 3859429 (1975-01-01), Elias
patent: 4057618 (1977-11-01), Salmon et al.
Rohrbach, M.S. "[Glycine-1-.sup.14 C]Hippuryl-L-Histidyl-L-Leucine]" analytical Biochemistry, 84,272-276 (1978).
Bhargava Kuldeep K.
Blaufox M. Donald
Chervu Lakshman R.
ALbert Einstein College of Medicine - of Yeshiva University
Maples John S
LandOfFree
Radioidohippuric acid ester, a conjugate thereof, and methods of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioidohippuric acid ester, a conjugate thereof, and methods of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioidohippuric acid ester, a conjugate thereof, and methods of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-580891